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Abstract
There is a need for trials on the effects of food aid 
products for children with moderate acute malnutri-
tion, to identify how best to restore body tissues and 
function. The choice of control intervention is a major 
challenge, with both ethical and scientific implications. 
While randomized trials are needed, special designs, 
such as cluster-randomized, stepped-wedged or fac-
torial designs may offer advantages. Anthropometry 
is widely used as the primary outcome in such trials, 
but anthropometric traits do not refer directly to spe-
cific organs, tissues, or functions. Thus, it is difficult 
to understand what components of health might be 
impacted by public health programs, or the underly-
ing mechanisms whereby improved nutritional status 
might benefit short- and long-term health. Measure-
ment of body composition, specific growth markers 
and functional outcomes may provide greater insight 
into the nature and implications of growth failure and 
recovery. There are now several methodologies suit-
able for application in infants and young children, e.g., 
measuring body composition with deuterium dilution, 
physical activity with accelerometers and linear growth 
with knemometers. To evaluate the generalizability of 
the findings from nutrition trials, it is important to 
collect data on baseline nutritional status.
Key words: food aid products, MAM, children, study 
design, outcomes
Introduction
There is a need for acceptable and affordable food aid 
products for children with moderate acute malnutri-
tion (MAM) that effectively restore body tissues and 
functions [1, 2]. If the supplement offered fails to meet 
the requirements for energy and specific nutrients, then 
the regain of body tissues and functions will be inad-
equate and the child may progress to severe acute mal-
nutrition (SAM) and die, or may survive with short- or 
long-term risks of infectious and chronic diseases and 
impaired physical and intellectual potential [3].
Therefore, it is important that the effects of poten-
tial products for treatment of acute malnutrition are 
assessed through sufficiently large randomized, con-
trolled trials to get accurate and precise effect estimates. 
This leads to two generic issues that are the focus of this 
paper. First, how should we design the trials in order to 
obtain the best-quality evidence regarding the efficacy 
of nutritional interventions? Second, what outcomes 
should we assess in order to demonstrate that the 
intervention improves health and reduces disease risk?
Study design issues
Nutritional randomized, controlled trials pose ethi-
cal and scientific challenges, and these challenges are 
different between MAM and SAM. For SAM, death 
is the outcome of greatest concern, but foods already 
exist that have proven to considerably reduce mortal-
ity. Hence, having an unsupplemented control group 
would be not only unethical but also scientifically 
irrelevant. For MAM, although progression to SAM 
and death may occur, these outcomes are uncommon. 
Hence, the design issues and choice of outcomes are 
different in MAM.
Control intervention
In trials among children with MAM, those in the 
control group are usually given “standard of care,” 
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even if no evidence for effect is available. Yet, recom-
mendations for treatment of MAM do not exist in all 
settings or are not implemented, or supplements are not 
always available. But even in settings where treatment 
is nonexistent, not giving any foods to children with 
MAM is not without ethical concerns. However, from 
the public health and scientific perspectives, it is also 
problematic to compare the effect of an experimental 
supplement with the effect of supplements that are not 
recommended or the effect of which is unknown. First, 
it is of questionable value in a low-income country to 
conduct a trial to compare an experimental supplement 
with a supplement that is not already standard of care, 
and national ethics committees may not grant permis-
sion for such a trial. Second, it is difficult to interpret 
findings from a trial comparing an experimental sup-
plement with one that has not been properly tested. 
Hence, where supplementation is not standard of care, 
it may be ethically justifiable to have an unsupple-
mented control group. In such cases, mothers should 
receive health education and the children should 
receive medical attention, be monitored closely, and be 
referred for further medical examination and treatment 
if they do not recover. Delayed supplementation may 
also be considered. 
Study design
Food interventions are complex, since supplements 
with the same energy content may be based on different 
ingredients, different processing methods, and differ-
ent forms and amounts of antinutrients and nutrients. 
Consequently, there is an infinite number of potential 
food supplements, yet only a few can be tested in trials, 
as such trials are costly. The traditional approach would 
be to decide on an experimental supplement and then 
test it against a control intervention in a randomized, 
controlled trial, with only two arms in order to maxi-
mize statistical power. However, there are a couple 
of alternative designs that may be used and that may 
address some of the difficulties experienced with the 
conventional randomized, controlled trial, i.e., risk of 
spillover between experimental and control interven-
tions, having an unsupplemented control group, and 
deciding on a single experimental supplement to test.
Cluster-randomized design
In a cluster-randomized trial, groups of individuals or 
treatment centers rather than individuals are the units 
of randomization. The advantage of this design is that 
it is operationally more feasible and the risk of spillover 
of the experimental intervention to the control group 
is lower. In contrast, it may be more difficult to blind 
the investigators as to which intervention the partici-
pants receive. Since the number of randomized units is 
lower, randomization will be less effective, and special 
statistical methods are needed to account for the fact 
that observations within a cluster are not independent. 
A cluster-randomized trial was recently conducted 
among children with MAM in Burkina Faso [4].
Stepped-wedge design
If a MAM intervention is to be implemented based on 
prior belief rather than evidence of benefit, then this 
design may be an option, provided it is not possible 
to implement the intervention simultaneously at all 
treatment sites. The rollout of the new intervention 
in geographic areas or treatment centers will then be 
sequential, based on randomization, and it will be pos-
sible to compare the effect of the new supplement with 
that of the existing supplement [5]. Thus, the design 
is basically cluster randomized, and individuals at all 
treatment sites, but not all individuals, will be given 
the new supplement. The randomization is considered 
to be without ethical concerns, since the intervention 
is withheld not for the purpose of research but as a 
logistical necessity. The limitations are similar to those 
of the cluster-randomized trial. A study on the effect 
of home-based therapy conducted in Malawi used a 
stepped-wedge design [6].
Factorial design
Some processing methods or components may be 
potentially important, but costly. If a combination of 
several factors is of interest, then a randomized trial 
using a factorial design may be needed. An example is 
the TreatFOOD trial in Burkina Faso among children 
with MAM (http://www.thelancet.com/protocol-
reviews/13PRT-4687). It is an individually randomized 
trial using a 2-by-2-by-3 factorial design among 1,600 
children to assess the effects of the food matrix (lipid-
based nutrient supplement [LNS] vs. corn-soy blend 
[CSB]), soy protein quality (dehulled vs. isolate), and 
milk protein content (0%, 8%, and 20 w/w %). Thus, the 
children are randomly assigned to 12 different foods. 
The design allows assessing for interactions among the 
three factors, i.e., if the effect of one factor depends on 
the presence of another factor. This could be the case 
if milk proves to have a greater effect if given in CBS 
than in LNS. If so, then it will be necessary to make 
comparisons among the 12 individual interventions. 
If there are no interactions, then the full power will be 
available to assess, say, the effect of milk, without taking 
food matrix and soy quality into consideration.
Generalizability
Assessing the effect of a nutritional intervention may be 
more complex than assessing the effect of, say, a drug 
against a specific disease. The effect of a given nutri-
tional intervention depends on the initial nutritional 
status and the background diet. Children with similar 
weight-for-height z-scores or mid-upper-arm circum-
ference (MUAC) values may have different growth 
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patterns, body composition, and micronutrient status 
and intake. Hence, the effect of the same intervention 
may be different between children and populations. 
Therefore, it is important to collect data on baseline 
nutritional status to assess for effect modification and 
evaluate the generalizability of the findings. 
Choice of outcomes
Our understanding of the effects of MAM in early 
life is primarily based on anthropometric measures—
mostly weight and height, which are often converted 
to age- and sex-specific z-scores, but which may also 
be expressed as weight-for-height or body mass index, 
also in z-score format [7]. Another widely used out-
come is MUAC, which in studies of children with SAM 
is a better predictor of mortality than weight-for-height 
[8]. One possibility is that MUAC acts as a better indi-
cator of muscle mass than does weight-for-height [9], 
but this requires confirmation, since in older children 
MUAC indexes adiposity much better than lean mass 
[10]. These data provide indices of stunting (short 
stature) and wasting (low weight-for-age, low MUAC), 
categorized using cutoffs [11, 12]. Much information 
can be gained from such measurements, and data can 
readily be compared across populations because of the 
standardized format. However, the abstract nature of 
anthropometry also means that much is also concealed 
by these outcomes. None of these anthropometric 
outcomes refers directly to specific organs, tissues, or 
functions, making it difficult to understand what com-
ponents of health might be impacted by public health 
programs or the underlying mechanisms whereby 
improved nutritional status might benefit short- and 
long-term health. 
Specific growth markers
Beyond whole-body anthropometry, more detailed 
measurements are increasingly recognized to provide 
greater insight into the nature of growth failure and 
recovery. The thrifty phenotype hypothesis proposed 
that the body responds to malnutrition by preserving 
some tissues and organs at the expense of others [13]. 
Studies have shown that the brain is generally spared, 
at the cost of reductions in growth of organs such as the 
pancreas, kidney, and liver [14]. This approach can also 
be extended to growth, with, for example, some body 
proportions being protected at the expense of others. 
Figure 1 illustrates deficits in specific body compo-
nents in high-altitude versus low-altitude Peruvian 
children, illustrating that some components of growth 
(e.g., trunk–head length, hand and foot lengths) are 
protected at the expense of others (e.g., tibia length)
[15]. Thus, growth traits may potentially provide proxy 
information for constraints on organ development; 
however, this hypothesis requires confirmation.
Measurements of specific body components can thus 
be made using customized equipment. Growth velocity 
of the legs is faster during early life than growth veloc-
ity of the rest of the body. Lower leg length contributes 
about 25% of total length at birth and about 29% at 
5 years [16]. There are some indications that foods 
containing dairy products have a specific effect on leg 
growth [17]. By subtracting crown–rump length, which 
can be measured with standard equipment used for 
measuring length, it is possible to estimate growth of 
the legs and compare it with growth of the rest of the 
body. Leg growth can be estimated with a knemom-
eter, a modified electronic caliper that measures linear 
growth velocity over short periods with high precision 
[18]. Head circumference can also be measured as a 
simple proxy for brain growth, which may be useful in 
studies on the potential effects of MAM on cognitive 
development.
Body composition
Measurement of body composition represents a novel 
approach to the assessment of nutritional status and 
may help to resolve some of this uncertainty. The 
simplest approach aims to differentiate fat from lean 
mass [19]. There is increasing recognition that these 
two traits have very different implications for short- 
and long-term outcomes [20]. Fat represents a store 
of energy that may fund immune function or future 
growth. Lean tissue represents functional organs and 
tissues, which may likewise contribute to immune 
function, but also in the longer term to diverse other 
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FIG. 1. Differences in growth z-scores between high-altitude 
and low-altitude children from Peru, demonstrating greater 
contrasts in total limb and lower limb lengths, intermediate 
differences in hand and foot lengths, and the smallest differ-
ence in head–trunk height [15]. 
Source: Reproduced under the terms of the Creative Commons 
Attribution License.
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aspects of health and function. The relative proportion 
of fat to lean provides an indication of how the body is 
allocating energy between these competing ends [21]. 
Low levels of fat may indicate reduced resilience to 
ecological stresses in the short-term future, whereas 
low levels of lean mass indicate cumulative exposure to 
prior stresses. The relative “survival” value of fat versus 
lean tissue in early life remains uncertain; hence it is 
unclear what constitutes the optimum pattern of tissue 
accretion during recovery from MAM, and whether 
variation in fat and lean accretion across populations 
represents local adaptation or simply different stresses. 
Equally, it remains unclear whether public health inter-
ventions should promote lean mass, fat, or a particular 
ratio of the two. These are key questions for the next 
generation of trials to assess.
Although measurements of skinfolds can be used 
to assess subcutaneous adiposity, they do not quantify 
whole-body fat content. Likewise, there is no reliable 
anthropometric marker of lean mass. Until recently, 
therefore, body composition was difficult to measure in 
young age groups with accuracy under field conditions; 
however, several techniques have now become avail-
able. Measurement of body water by isotope dilution 
is the only technique that can be used in all age groups 
[22], while air displacement plethysmography (ADP), 
a form of densitometry known as the Peapod, can be 
used from birth to 6 to 8 months, depending on the 
size of the infant [23]. Both of these techniques assume 
constant properties of lean tissue when raw data are 
converted into final body composition values; however, 
this assumption may be invalidated during chronic 
malnutrition. This issue can be solved in younger age 
groups by combining the two methods, thereby meas-
uring the hydration and density of lean tissue [23]. 
Recent studies have successfully used isotopes and ADP 
in large samples of infants in developing countries* [23] 
demonstrating their suitability for future trials. 
Bioelectrical impedance analysis (BIA) has con-
ventionally been used to predict total body water and 
hence lean and fat masses, but it has low accuracy in 
individuals [19]. However, bioelectrical impedance 
vector analysis (BIVA) is a newer variant [24], which 
analyzes more detailed bioelectrical properties of lean 
tissue. Although the outcomes are expressed in abstract 
bioelectrical units, BIVA is showing promise for differ-
entiating variability in lean tissue mass from variability 
in hydration in children with MAM and SAM** (and 
may prove particularly valuable for the assessment of 
* Skau, J. Preventing undernutrition in Cambodia: As-
sessing the effect of improved local complementary food on 
growth. PhD thesis. University of Copenhagen, 2013. ISBN 
978-87-7611-633-0. (unpublished)
** Girma, T. Bioimpedance in severely malnourished chil-
dren: An emerging method for monitoring hydration of chil-
dren with severe acute malnutrition. PhD thesis. University of 
Copenhagen, 2014. ISBN 978-87-7611-782-5 (unpublished)
body composition in populations where the severity of 
malnutrition extends to both categories.
Finally, ultrasound can be used to assess the size of 
organs such as the thymus, liver, and kidney [25]. For 
example, thymus size has been shown to mediate asso-
ciations between nutritional status and infant mortality 
[26, 27]. Such data may be particularly valuable when 
acquired in combination with functional outcomes, as 
described below.
Whichever technique is selected, a key requirement 
is reference data, enabling data from individuals or 
trial groups to be assessed relative to normal ranges. 
Reference data have now been published for ADP in 
Ethiopian infants [23], and BIVA data are also being 
acquired. Other studies have collected isotope meas-
urements of body water in large samples [28]. These 
emerging data are enabling the evaluation of the body 
composition characteristics underlying MAM and will 
help clarify its etiology and response to treatment.
Functional outcomes
While measurement of body composition can contrib-
ute novel information on the etiology of MAM and its 
response to treatment, it is also useful to have infor-
mation on physiological function, in order to improve 
health assessment. The range of possible outcomes 
increases with age, as older children are able to comply 
with more complex protocols.
Blood pressure represents a valuable marker of 
homeostasis, and studies have already clarified that 
growth patterns in fetal life and infancy are associated 
with short- and long-term variability in this outcome 
[29, 30]. At older ages, outcomes such as grip strength, 
measured by dynamometry, can provide information 
on muscle function, while respirometry can be used to 
assess lung function [31, 32]. 
A variety of indices of cognitive or psychomotor 
ability can be assessed by developmental scales, which 
may need adapting to local cultural settings [33]. 
Physical activity can be assessed with questionnaires 
to quantify patterns of behavior, or accelerometers can 
be used to assess the intensity and duration of body 
movements [34]. 
Finally, blood samples clearly allow a wide range of 
markers of immune function to be assessed, as well as 
diverse parameters of metabolic health, such as glucose 
homeostasis and lipid profile. These outcomes are 
of especial importance, given growing evidence that 
growth patterns in early life may predict later risk of 
obesity and the metabolic syndrome [35].
A key point is that associations between early growth 
or nutritional status and later health outcomes in 
industrialized countries may not extend to popula-
tions in developing countries. Whereas rapid infant 
growth appears to exacerbate the risks of obesity and 
the metabolic syndrome in industrialized countries [36, 
S39Trials among children with moderate acute malnutrition
37], the available evidence indicates that early rapid 
growth in developing countries boosts survival [38] 
and has beneficial effects on lean mass and homeostasis 
[37]. This difference may relate to variable durations 
between populations during which “critical windows” 
are sensitive to nutrition [39]; however, this hypothesis 
requires further testing.
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